KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Net Income: 2011-2024

Historic Net Income for Sarepta Therapeutics (SRPT) over the last 14 years, with Dec 2024 value amounting to $235.0 million.

  • Sarepta Therapeutics' Net Income fell 7028.08% to -$447.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$248.7 million, marking a year-over-year decrease of 627.64%. This contributed to the annual value of $235.0 million for FY2024, which is 143.83% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Net Income stood at $235.0 million for FY2024, which was up 143.83% from -$536.1 million recorded in FY2023.
  • In the past 5 years, Sarepta Therapeutics' Net Income ranged from a high of $235.0 million in FY2024 and a low of -$704.1 million during FY2022.
  • Its 3-year average for Net Income is -$335.1 million, with a median of -$536.1 million in 2023.
  • Per our database at Business Quant, Sarepta Therapeutics' Net Income plummeted by 68.13% in 2022 and then spiked by 143.83% in 2024.
  • Yearly analysis of 5 years shows Sarepta Therapeutics' Net Income stood at -$554.4 million in 2020, then increased by 24.46% to -$418.8 million in 2021, then tumbled by 68.13% to -$704.1 million in 2022, then increased by 23.85% to -$536.1 million in 2023, then spiked by 143.83% to $235.0 million in 2024.